“These 2 Penny Stocks Could Surge Over 200%, Says Raymond James”
December 9, 2020
“ADMA Biologics (ADMA)…
Are other analysts in agreement? They are. Only Buy ratings, 5, in fact, have been issued in the last three months, so the consensus rating is a Strong Buy. Given the $6.65 average price target, shares could skyrocket 242% in the next year…
InflaRx NV (IFRX)…
Turning to the rest of the Street, 3 Buys and 1 Hold have been assigned in the last three months. Therefore, IFRX has a Strong Buy analyst consensus. With an average price target of $10.50, shares could soar 161% in the year ahead…”
https://finance.yahoo.com/news/2-penny-stocks-could-surge-163517880.html